Docoh
Loading...
Sign up Log in

IMPL Impel NeuroPharma

Company profile

Ticker
IMPL
Exchange
NASDAQ
Employees
Incorporated
Delaware
Location
Washington
Fiscal year end
Dec 31
Sector
Health Technology > Other Health Care
Industry (SIC)
Pharmaceutical Preparations
Pfizer • Johnson & Johnson • Merck & Co • Allergan • Abbott Laboratories • Teva- Pharmaceutical Industries • Lilly(Eli) & Co • Viatris • Bristol-Myers Squibb • Warner Chilcott ...
SEC CIK
0001445499
Corporate docs
IRS number
263058238

IMPL stock data

(
)

News

Pro users get this 30m faster
The Week Ahead In Biotech: Sanofi, Bristol-Myers Squibb Await FDA Decisions, Earnings News Flow Tapers Off
15 May 21
Biotech stocks had a volatile ride in the week ended May 14, with stocks moving broadly lower for much of the week before coming back up strongly in the final session. Some of the weakness may be traced back to the across-the-board weakness in markets, as macroeconomic fears unnerved traders.
The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts
14 May 21
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 13)
Last Week's Notable Insider Buys: Beacon Roofing, Chipotle, IPOs, Latham And More
2 May 21
Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Once again, some insiders took advantage of recent public share offerings to add or bolster stakes. Again, biotechnology companies are well represented on this list.
The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout
27 Apr 21

Press releases

Pro users get this 30m faster
Impel NeuroPharma Announces Pricing of $80.0 Million Initial Public Offering
22 Apr 21
SEATTLE, April 22, 2021 (GLOBE NEWSWIRE) -- Impel NeuroPharma, Inc. (Impel), a late-stage pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize transformative therapies for

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

16 May 21
31 Dec 21

Recent insider trades

IMPL insider ownership history Insider history
Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
27 Apr 21 KKR Iris Investors Common Stock Buy Aquire P Yes No 15 1,100,000 16.5M 3,802,638
27 Apr 21 KKR Iris Investors Common Stock Other Aquire J Yes No 13.5 118,712 1.6M 2,702,638
27 Apr 21 KKR Iris Investors Common Stock Conversion Aquire C Yes No 0 2,583,926 0 2,583,926
27 Apr 21 KKR Iris Investors Series D Preferred Stock Common Stock Conversion Dispose C Yes No 0 42,307,448 0 0
27 Apr 21 John Hoekman Common Stock Other Dispose J No No 0 275 0 108,221
27 Apr 21 John Hoekman Common Stock Conversion Aquire C No No 0 4,523 0 108,496
27 Apr 21 John Hoekman Series A-2 Preferred Stock Common Stock Conversion Dispose C No No 0 69,657 0 0
27 Apr 21 John Hoekman Series A-2 Preferred Stock Common Stock Aquire X No No 0 8,523 0 69,657
27 Apr 21 John Hoekman Series A-2 Warrants Series A-2 Preferred Stock Dispose X No No 8.19 8,523 69.8K 0
27 Apr 21 Parker H Stewart Common Stock Conversion Aquire C No No 13.5 271 3.66K 18,027
Data from 3, 4 and 5 filings. Stock values as filed, not updated for current price.

Institutional ownership Q4 2020

IMPL institutional ownership history Ownership history

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

13F holders
 Current Prev Q Change
Total holders 0 0
Opened positions 0 0
Closed positions 0 0
Increased positions 0 0
Reduced positions 0 0
13F shares
 Current Prev Q Change
Total value 0 0
Total shares 0 0
Total puts 0 0
Total calls 0 0
Total put/call ratio – – –
Largest owners
 Shares Value Change
Largest transactions
 Shares Bought/sold Change
Data from 13F filings. Stock values as filed, not updated for current price. Long positions only.

Financial reports

No filings

Current reports

No filings

Registration and prospectus

View all
S-8
Registration of securities for employees
23 Apr 21
424B1
Prospectus with pricing info
23 Apr 21
8-A12B
Registration of securities on exchange
19 Apr 21
S-1/A
IPO registration (amended)
19 Apr 21
S-1
IPO registration
2 Apr 21
D
$1.93M in options / securities to be acquired, 1 investor
1 Apr 21
DRS/A
Draft registration statement (amended)
22 Mar 21
D
$7.5M in debt, sold $7.5M, 8 investors
12 Mar 21
D
$490K in options / securities to be acquired, 2 investors
17 Feb 21
DRS
Draft registration statement
11 Feb 21

Proxies

No filings

Other

EFFECT
Notice of effectiveness
23 Apr 21

Ownership

View all
SC 13D
IMPEL NEUROPHARMA / KKR Iris Investors ownership change
7 May 21
SC 13G
IMPEL NEUROPHARMA / 5AM Ventures V ownership change
7 May 21
SC 13G
IMPEL NEUROPHARMA / venBio Global Strategic Fund II ownership change
7 May 21
SC 13G
IMPEL NEUROPHARMA / Vivo Capital VIII ownership change
6 May 21
4
Change in insider ownership
29 Apr 21
4
IMPEL NEUROPHARMA / SCOTT M ROCKLAGE ownership change
29 Apr 21
4
IMPEL NEUROPHARMA / PROMOD HAQUE ownership change
29 Apr 21
4
IMPEL NEUROPHARMA / COREY S GOODMAN ownership change
29 Apr 21
4
IMPEL NEUROPHARMA / H STEWART PARKER ownership change
29 Apr 21
4
IMPEL NEUROPHARMA / John Hoekman ownership change
29 Apr 21

Patents

View all
GRANT
Utility
Nozzles for nasal drug delivery
9 Mar 21
A nozzle for use in delivering a mixture of aerosol propellant and drug formulation.
APP
Utility
Intranasal Delivery of Dihydroergotamine by Precision Olfactory Device
28 Jan 21
Methods are provided for acutely treating migraine headache with or without aura.
APP
Utility
Single-Use Nasal Delivery Device
18 Nov 20
Embodiments relate to a single-use device for delivery of medication into a nasal cavity.
APP
Utility
Medical Unit Dose Container
1 Apr 20
A unit dose container for the containment of an intranasal formulation for use with the POD device.
APP
Utility
Nasal Drug Delivery Device
11 Mar 20
A compound delivery device for delivering a plume derived from a propellant and a drug formulation.

Reddit threads

Pro users get this 30m faster